Canada markets closed

Kezar Life Sciences, Inc. (2KZ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7150+0.0250 (+3.62%)
At close: 08:01AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
7,000
0
0
0
Operating Expenses
Research Development
45,931
85,697
51,009
38,935
30,981
Selling General and Administrative
19,300
26,540
20,153
15,724
11,969
Total Operating Expenses
65,231
112,237
71,162
54,659
42,950
Operating Income or Loss
-65,231
-105,237
-71,162
-54,659
-42,950
Interest Expense
995
1,550
1,185
159
0
Total Other Income/Expenses Net
-6,187
-6,187
-
-
-
Income Before Tax
-64,270
-101,870
-68,239
-54,630
-41,742
Income from Continuing Operations
-64,270
-101,870
-68,239
-54,630
-41,742
Net Income
-64,270
-101,870
-68,239
-54,630
-41,742
Net Income available to common shareholders
-64,270
-101,870
-68,239
-54,630
-41,742
Basic EPS
-1.21
-
-1.01
-1.04
-0.95
Diluted EPS
-1.21
-
-1.01
-1.04
-0.95
Basic Average Shares
72,440
-
67,369
52,759
44,004
Diluted Average Shares
72,440
-
67,369
52,759
44,004